OTC : ERFSF

Eurofins Scientific SE

$82.55 USD

$1.36 (1.68%)

Volume
790
Average Volume
4.54K
Market Capitalization
$14.26B
P/E Ratio
23.27
Dividend Yield
1.03%
Price Target
Year High
$86.20
Year Low
$64.95
Day High
—
Day Low
—
Payout Ratio
$0.25
Current Ratio
$1.13
Company Overview

OTC

Gilles G. Martin

Medical - Diagnostics & Research

Healthcare

ERFSF

65694

LU

USD

https://www.eurofins.com

352 26 18 53 20

N/A

N/A

Liquidity Metrics

1.51

1.13

1.07

0.25

0.25

Sales & Valuation

$7.29B

1.63

3.38

19.00

3.62

Profitability

$2.54

$474.82M

7.18%

9.84%

14.81%

4.77%

P/E Metrics

23.27

0.63

0.63

Analyst Price Target & Rating

Neutral

3/5

4 Analysts

%

Financial Health Scores

3.24

6/9

$326.51M

$11.09B

$7.44B

$1.77B

Key Metrics (TTM)

$16.91B

2.29

11.35

1.13

14.81%

6.83%

4.33%

5.26%

$37.45

48 days

Company Executives
Name Title
Brian Williams Executive Vice President of Environment Testing North America & Regional Multi Business Lines Leader Pacific
Timothy S. Oostdyk Executive Vice President of BioPharma, Genomics & Agrosciences Services North America
Bernard Wang Head of Investor Relations
David W. Bryant Senior Vice President of Strategic Business Development North America
Joachim Reichelt Senior Vice President of Food & Feed Testing Europe
Laurent Lebras Group Administration & Chief Financial Officer
Valerie Hanote Executive Director
Yvoine Remy Senior Vice President of Environment Testing Europe
Gilles G. Martin Chairman of the Board & Chief Executive Officer
Francois Vigneau Senior Vice President of Food & Feed Testing - Western Europe
Gabriel Julia Senior Vice President of Clinical Diagnostics Europe
Poll Results

No votes yet today — be the first to share your view!

About Eurofins Scientific SE (OTC:ERFSF) Stock

Eurofins Scientific SE, along with its affiliated companies, delivers a broad spectrum of analytical testing and laboratory solutions globally. The firm utilizes an extensive repertoire of approximately 200,000 analytical techniques, designed to assess various product attributes such as safety, identification, makeup, genuineness, source, trackability, and cleanliness. Its offerings span numerous sectors. These include agro-science, encompassing biological evaluations, consumer, human, and environmental safety assessments, product chemical analysis, regulatory guidance, and seed services. The company also handles general agro testing. Its assurance division provides product inspections, audits, certifications, training, and advisory services for items across food, consumer goods, healthcar ... e, and cosmetics industries. Other specialized areas are biopharma and clinical diagnostics. Furthermore, Eurofins conducts comprehensive consumer product testing, covering compliance, audits, examinations, certifications, inspections, training programs, and digital media and cybersecurity solutions for a diverse range of sectors. It also specializes in cosmetics and personal care product analysis, and environmental testing for substances like water, air, soil, waste, and other materials. Food and feed testing is another key segment, addressing concerns such as allergens, GMOs, grain quality, meat composition, nanomaterials, pesticides, and residual DNA. The company's extensive food-related portfolio also includes audit and certification services, authenticity verification, carbohydrate analysis, consulting, detection of dioxins and persistent organic pollutants (POPs), food irradiation checks, labeling compliance, legal guidance, heavy metal screening, identity preservation, mealtime analysis, molecular and microbiology testing, mycotoxin detection, nutritional profiling, organic contaminant analysis, packaging and migration studies, radioactivity testing, rapid testing methods, sensory and consumer research, various training initiatives, veterinary drug residue screening, and vitamin content analysis. Beyond these, Eurofins offers expertise in forensic science, genomics, maritime applications, materials and engineering, REACH compliance, and advanced technologies. The company maintains a significant global presence, operating roughly 900 laboratories across 54 nations. Established in 1987, its main office is situated in Luxembourg City, Luxembourg.

Eurofins Scientific: Director/PDMR Shareholding

2026-08-07 11:48:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the per.

Eurofins Scientific SE: Director/PDMR Shareholding

2026-08-03 11:37:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the p.

Eurofins Scientific: Director/PDMR Shareholding

2026-07-31 09:34:00

LUXEMBOURG.--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the.

Eurofins Scientific: Director/PDMR Shareholding

2026-07-29 10:02:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the per.

Comparing Eurofins Scient (OTCMKTS:ERFSF) & Intelligent Bio Solutions (NASDAQ:INBS)

2026-07-26 01:45:21

Intelligent Bio Solutions (NASDAQ: INBS - Get Free Report) and Eurofins Scient (OTCMKTS:ERFSF - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Profitability This table compares Intelligent Bio Solutions

Eurofins Scientific SE (ERFSF) Q2 2026 Earnings Call Transcript

2026-07-24 17:00:37

Eurofins Scientific SE (ERFSF) Q2 2026 Earnings Call Transcript

Eurofins Scientific: Director/PDMR Shareholding

2026-07-24 10:57:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the p.

Eurofins Scientific: Director/PDMR Shareholding

2026-07-21 11:41:00

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM     1. Details of the p.

Frequently Asked Questions

What is the current Eurofins Scientific SE (ERFSF) stock price?

Eurofins Scientific SE(OTC:ERFSF) stock price is $82.55 in the last trading session. During the trading session, ERFSF stock reached the peak price of $86.2 while $64.95 was the lowest point it dropped to. The percentage change in ERFSF stock occurred in the recent session was 1.68% while the dollar amount for the price change in ERFSF stock was $1.36.

ERFSF's industry and sector of operation?

The OTC listed ERFSF is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.

Who are the executives of ERFSF?

Brian Williams | Executive Vice President of Environment Testing North America & Regional Multi Business Lines Leader Pacific
Timothy S. Oostdyk | Executive Vice President of BioPharma, Genomics & Agrosciences Services North America
Bernard Wang | Head of Investor Relations
David W. Bryant | Senior Vice President of Strategic Business Development North America
Joachim Reichelt | Senior Vice President of Food & Feed Testing Europe

How many employees does ERFSF have?

Number of ERFSF employees currently stands at 65694. ERFSF operates from 23 Val Fleuri, Luxembourg City, LU 1526, LU.

Link for ERFSF official website?

Official Website of ERFSF is: https://www.eurofins.com

How do I contact ERFSF?

ERFSF could be contacted at phone #352 26 18 53 20 and can also be accessed through its website. ERFSF operates from 23 Val Fleuri, Luxembourg City, LU 1526, LU.

How many shares of ERFSF are traded daily?

The average number of ERFSF shares traded daily for last 3 months was 4.54K.

What is the market cap of ERFSF currently?

The market value of ERFSF currently stands at $14.26B with its latest stock price at $82.55